Literature DB >> 20056538

Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors.

Takayoshi Suzuki1, Rikako Tanaka, Shohei Hamada, Hidehiko Nakagawa, Naoki Miyata.   

Abstract

To identify novel non-nucleoside DNA methyltransferase (DNMT) inhibitors, we designed and synthesized a series of maleimide derivatives. Among this series, compounds 5-8 were found to be more potent DNMT1 inhibitors than RG108, a DNMT1 inhibitor reported previously by Siedlecki et al. The binding mode analysis of compound 5 is also reported. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20056538     DOI: 10.1016/j.bmcl.2009.12.016

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  18 in total

1.  DNA methyl transferase 1: regulatory mechanisms and implications in health and disease.

Authors:  Sirano Dhe-Paganon; Farisa Syeda; Lawrence Park
Journal:  Int J Biochem Mol Biol       Date:  2011-01-30

Review 2.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

3.  Homology modeling, docking and structure-based pharmacophore of inhibitors of DNA methyltransferase.

Authors:  Jakyung Yoo; José L Medina-Franco
Journal:  J Comput Aided Mol Des       Date:  2011-06-10       Impact factor: 3.686

Review 4.  Targeting DNA methylation for epigenetic therapy.

Authors:  Xiaojing Yang; Fides Lay; Han Han; Peter A Jones
Journal:  Trends Pharmacol Sci       Date:  2010-09-16       Impact factor: 14.819

5.  Resveratrol-salicylate derivatives as selective DNMT3 inhibitors and anticancer agents.

Authors:  Fahad S Aldawsari; Rodrigo Aguayo-Ortiz; Kanishk Kapilashrami; Jakyung Yoo; Minkui Luo; José L Medina-Franco; Carlos A Velázquez-Martínez
Journal:  J Enzyme Inhib Med Chem       Date:  2015-06-29       Impact factor: 5.051

Review 6.  Trials with 'epigenetic' drugs: an update.

Authors:  Angela Nebbioso; Vincenzo Carafa; Rosaria Benedetti; Lucia Altucci
Journal:  Mol Oncol       Date:  2012-10-06       Impact factor: 6.603

Review 7.  Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments.

Authors:  Tung On Yau; Ceen-Ming Tang; Jun Yu
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

8.  Epigenetic therapy in allogeneic hematopoietic stem cell transplantation.

Authors:  Qaiser Bashir; Basem Magdy William; Guillermo Garcia-Manero; Marcos de Lima
Journal:  Rev Bras Hematol Hemoter       Date:  2013

Review 9.  Epigenetic-based therapies in cancer: progress to date.

Authors:  Sang-Hyun Song; Sae-Won Han; Yung-Jue Bang
Journal:  Drugs       Date:  2011-12-24       Impact factor: 11.431

10.  Specific inhibition of one DNMT1-including complex influences tumor initiation and progression.

Authors:  Mathilde Cheray; Romain Pacaud; Arulraj Nadaradjane; François M Vallette; Pierre-François Cartron
Journal:  Clin Epigenetics       Date:  2013-06-28       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.